PH31582A - Glycoslated cytokins. - Google Patents

Glycoslated cytokins.

Info

Publication number
PH31582A
PH31582A PH46943A PH46943A PH31582A PH 31582 A PH31582 A PH 31582A PH 46943 A PH46943 A PH 46943A PH 46943 A PH46943 A PH 46943A PH 31582 A PH31582 A PH 31582A
Authority
PH
Philippines
Prior art keywords
glycoslated
cytokins
cytokine
liver
sugar
Prior art date
Application number
PH46943A
Other languages
English (en)
Inventor
Hamaguchi Naoru
Doken Kazuhiro
Jun Sato
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of PH31582A publication Critical patent/PH31582A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
PH46943A 1992-09-24 1993-09-23 Glycoslated cytokins. PH31582A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25496292 1992-09-24
JP8892093 1993-04-15

Publications (1)

Publication Number Publication Date
PH31582A true PH31582A (en) 1998-11-03

Family

ID=26430256

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46943A PH31582A (en) 1992-09-24 1993-09-23 Glycoslated cytokins.

Country Status (9)

Country Link
US (1) US5643564A (ja)
EP (1) EP0589378B1 (ja)
KR (1) KR940007058A (ja)
CN (1) CN1087916A (ja)
AT (1) ATE229981T1 (ja)
CA (1) CA2106821A1 (ja)
DE (1) DE69332576T2 (ja)
PH (1) PH31582A (ja)
TW (1) TW263437B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0770195A (ja) * 1993-08-23 1995-03-14 Yutaka Mizushima 糖修飾インターフェロン
IL116730A0 (en) * 1995-01-13 1996-05-14 Amgen Inc Chemically modified interferon
DE69636112T2 (de) * 1995-08-30 2006-12-14 Toray Industries, Inc. Verfahren zum testen von myocarditis und cardiomyopathie
AUPP660698A0 (en) * 1998-10-21 1998-11-12 University Of Queensland, The A method of protein engineering
AR078117A1 (es) 2006-06-20 2011-10-19 Protech Pharma S A Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina
EP2680822B1 (en) * 2011-03-02 2022-02-23 Sensulin, LLC Vesicle compositions
TWI821192B (zh) 2017-07-11 2023-11-11 美商新索思股份有限公司 非天然核苷酸之導入及其方法
BR112020002271A2 (pt) 2017-08-03 2020-07-28 Synthorx, Inc. conjugados de citocina para o tratamento de doenças proliferativas e infecciosas
CN114949240A (zh) 2019-02-06 2022-08-30 新索思股份有限公司 Il-2缀合物及其使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386026A (en) * 1981-04-20 1983-05-31 Merck & Co., Inc. Cell-specific glycopeptide ligands
DE3380726D1 (en) * 1982-06-24 1989-11-23 Japan Chem Res Long-acting composition
JP2514950B2 (ja) * 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質，その製造法および中間体
JPS63152393A (ja) * 1986-07-03 1988-06-24 Takeda Chem Ind Ltd グリコシル誘導体
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
US5162503A (en) * 1987-05-19 1992-11-10 Hoffmann-La Roche, Inc. Purification of interleukin-2 by receptor-affinity chromatography
US4829690A (en) * 1987-06-26 1989-05-16 Andros Theodore A Credit card chain holder
JPH01102099A (ja) * 1987-10-14 1989-04-19 Toray Ind Inc 生理活性を有する糖タンパク質
JPH01102098A (ja) * 1987-10-14 1989-04-19 Toray Ind Inc 糖鎖修飾糖タンパク質
US4902502A (en) * 1989-01-23 1990-02-20 Cetus Corporation Preparation of a polymer/interleukin-2 conjugate
JPH03106900A (ja) * 1989-09-20 1991-05-07 Toray Ind Inc 糖鎖修飾ヒトインターフェロン集合体
JPH085914B2 (ja) * 1990-02-16 1996-01-24 株式会社ディ・ディ・エス研究所 グリコシル−蛋白誘導体
US5096816A (en) * 1990-06-05 1992-03-17 Cetus Corporation In vitro management of ammonia's effect on glycosylation of cell products through pH control
JPH0770195A (ja) * 1993-08-23 1995-03-14 Yutaka Mizushima 糖修飾インターフェロン

Also Published As

Publication number Publication date
CA2106821A1 (en) 1994-03-25
CN1087916A (zh) 1994-06-15
DE69332576D1 (de) 2003-01-30
ATE229981T1 (de) 2003-01-15
TW263437B (ja) 1995-11-21
DE69332576T2 (de) 2003-11-20
EP0589378A3 (en) 1995-02-22
US5643564A (en) 1997-07-01
EP0589378B1 (en) 2002-12-18
EP0589378A2 (en) 1994-03-30
KR940007058A (ko) 1994-04-26

Similar Documents

Publication Publication Date Title
MX9700081A (es) Composiciones farmaceuticas de tacrina.
GR3022060T3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
ZA913282B (en) Dosage form
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
AU7589587A (en) Low dosage of interferon to enhance vaccine efficiency
GR900100659A (en) Dosage form for administering oral hupoglycemic glipizide
NO306377B1 (no) Doseform for avgivelse av et medikament
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
ATE316792T1 (de) Stimulierung wirtseigener abwehrmechanismen gegen krebs
CA2116562A1 (en) Morphogen-Induced Modulation of Inflammatory Response
GR3017891T3 (en) Dosage form for delivering drug in short-time period.
GEP20002142B (en) Method for Treatment and Prevention of TNF Mediated Diseases
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
NO923859L (no) Medikament
CS545686A1 (en) Farmaceuticky prostredek a antihepatotoxickym pusobenim
PH31582A (en) Glycoslated cytokins.
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
GR3025372T3 (en) Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients
ZA896246B (en) Defective hepadnaviruses for vaccines and treatment of liver diseases and disorders
GR3023645T3 (en) Treatment of liver cancer
AU9139091A (en) Oral administration of alpha interferon to treat lung malignancies
DE3689254D1 (de) Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation.
HU9501641D0 (en) Transdermal administration systhm containig acetylsalicylic acid for antithromboitc therapy and the preventio of cancer
IL90206A0 (en) Pharmaceutical compositions for reducing the side effects of tnf
GB9124275D0 (en) New radical scavenging and antilipoperoxidant flavanolignans their preparation and formulations for therapeutic use